| Evaluation of PKU UP (NCT05995717) | Vitaflo International, Ltd | 2024-01-11 |
| Evaluation of PKU Explore France (NCT04898829) | Vitaflo International, Ltd | 2022-05-18 |
| Evaluation of TYR Sphere in France (NCT04761588) | Vitaflo International, Ltd | 2021-12-01 |
| Evaluation of the Express Plus Range (NCT05051657) | Vitaflo International, Ltd | 2021-06-14 |
| Evaluation of PDE MAX (NCT04672226) | Vitaflo International, Ltd | 2021-06-01 |
| Evaluation of PKU Sphere in Italy (NCT04679467) | Vitaflo International, Ltd | 2020-08-10 |
| Evaluation of Ketoflo (NCT04399954) | Vitaflo International, Ltd | 2020-02-24 |
| Evaluation of TYR Sphere (NCT04196959) | Vitaflo International, Ltd | 2019-10-01 |
| Evaluation of PKU Sphere in Maternal PKU (NCT04224142) | Vitaflo International, Ltd | 2019-07-29 |
| The Effects of CGMP in Children and Adults With PKU (NCT04076176) | Vitaflo International, Ltd | 2019-04-26 |
| A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU (NCT03771391) | Vitaflo International, Ltd | 2018-12-06 |
| Evaluation of Krio in Children and Adults With Epilepsy (NCT03202108) | Vitaflo International, Ltd | 2018-05-11 |
| Evaluation of PKU Sphere (NCT03419819) | Vitaflo International, Ltd | 2018-05-01 |
| Evaluation of Renastep (NCT03602937) | Vitaflo International, Ltd | 2018-04-17 |